M., Casazza, G., Iansa, P., Volpi, S
doi: 10.1111/dom.14054 27 LaurentSBrietMBoutouyrieP
These factors include metabolic defects, hypoxia caused by hemoglobin glycation, changes in red blood cell membrane permeability (Brem and Tomic-Canic, 2007), and narrowing of blood vessels
(September 2023) Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis (September 2023) As Semaglutides Popularity Soars, Rare but Serious Adverse Effects Are Emerging (November 2023) Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the UglyBenefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying (January 2024) Diabetic gastroparesis: a disease for which long-term therapeutic benefits are difficult to obtain (May 2024) Other Possible Side Effects of Zepbound Explored Tirzepatide, the active ingredient in Zepbound, belongs to a class of drugs called GLP-1 agonists